Average Co-Inventor Count = 7.18
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (22 from 2,405 patents)
2. Schering Corporation (6 from 1,829 patents)
3. Msd Italia S.r.l. (2 from 7 patents)
28 patents:
1. 12246008 - 4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channels
2. 12195445 - 2-amino-N-heteroaryl-nicotinamides as Na1.8 inhibitors
3. 11802122 - 2-oxoimidazolidine-4-carboxamides as NA1.8 inhibitors
4. 11377438 - 2-amino-n-heteroaryl-nicotinamides as Na1.8 inhibitors
5. 10766919 - Cyclic di-nucleotide compounds as sting agonists
6. 10414774 - Compound useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolc disease
7. 10414775 - Compounds useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolic disease
8. 10047098 - C5-C6-oxacyclic fused iminopyrimidinone compounds as bace inhibitors, compositions, and their use
9. 9809568 - Compounds inhibiting leucine-rich repeat kinase enzyme activity
10. 9745324 - Iminothiadiazepane dioxide compounds as BACE inhibitors, compositions, and their use
11. 9718818 - Compounds inhibiting leucine-rich repeat kinase enzyme activity
12. 9688654 - Compounds inhibiting leucine-rich repeat kinase enzyme activity
13. 9573939 - Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases
14. 9549917 - Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases
15. 9493461 - Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C